BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 30755260)

  • 21. CD11b
    Jin SH; Lee SB
    Tuberculosis (Edinb); 2023 May; 140():102345. PubMed ID: 37116235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer.
    Kumar S; Wilkes DW; Samuel N; Blanco MA; Nayak A; Alicea-Torres K; Gluck C; Sinha S; Gabrilovich D; Chakrabarti R
    J Clin Invest; 2018 Nov; 128(11):5095-5109. PubMed ID: 30295647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.
    Zhou J; Donatelli SS; Gilvary DL; Tejera MM; Eksioglu EA; Chen X; Coppola D; Wei S; Djeu JY
    Sci Rep; 2016 Jul; 6():29521. PubMed ID: 27405665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
    J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
    Kapanadze T; Medina-Echeverz J; Gamrekelashvili J; Weiss JM; Wiltrout RH; Kapoor V; Hawk N; Terabe M; Berzofsky JA; Manns MP; Wang E; Marincola FM; Korangy F; Greten TF
    Eur J Immunol; 2015 Apr; 45(4):1148-58. PubMed ID: 25616156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.
    Balog JÁ; Hackler L; Kovács AK; Neuperger P; Alföldi R; Nagy LI; Puskás LG; Szebeni GJ
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
    Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
    Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment.
    Fu SY; Chen FH; Wang CC; Yu CF; Chiang CS; Hong JH
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1547-1558. PubMed ID: 33188861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
    Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
    Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MCP-1/CCL2 Mediated by Autocrine Loop of PDGF-BB Promotes Invasion of Lung Cancer Cell by Recruitment of Macrophages Via CCL2-CCR2 Axis.
    Ding M; He SJ; Yang J
    J Interferon Cytokine Res; 2019 Apr; 39(4):224-232. PubMed ID: 30730243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis.
    Yang L; Edwards CM; Mundy GR
    J Bone Miner Res; 2010 Aug; 25(8):1701-6. PubMed ID: 20572008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
    Sangaletti S; Tripodo C; Santangelo A; Castioni N; Portararo P; Gulino A; Botti L; Parenza M; Cappetti B; Orlandi R; Tagliabue E; Chiodoni C; Colombo MP
    Cell Rep; 2016 Sep; 17(1):233-248. PubMed ID: 27681434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer.
    Yang G; Shen W; Zhang Y; Liu M; Zhang L; Liu Q; Lu HH; Bo J
    Oncotarget; 2017 Jun; 8(24):38378-38388. PubMed ID: 28418913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gr-1intCD11b+ myeloid-derived suppressor cells accumulate in corneal allograft and improve corneal allograft survival.
    Choi W; Ji YW; Ham HY; Yeo A; Noh H; Jin SE; Song JS; Kim HC; Kim EK; Lee HK
    J Leukoc Biol; 2016 Dec; 100(6):1453-1463. PubMed ID: 27370015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gr-1+CD11b+ cells facilitate Lewis lung cancer recurrence by enhancing neovasculature after local irradiation.
    Liu T; Xie C; Ma H; Zhang S; Liang Y; Shi L; Yu D; Feng Y; Zhang T; Wu G
    Sci Rep; 2014 Apr; 4():4833. PubMed ID: 24776637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.
    Li Z; Pang Y; Gara SK; Achyut BR; Heger C; Goldsmith PK; Lonning S; Yang L
    Int J Cancer; 2012 Dec; 131(11):2584-95. PubMed ID: 22487809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
    Cheng X; Jin Z; Ji X; Shen X; Feng H; Morgenlander W; Ou B; Wu H; Gao H; Ye F; Zhang Y; Peng Y; Liang J; Jiang Y; Zhang T; Qiu W; Lu X; Zhao R
    Int J Cancer; 2019 Jul; 145(1):179-191. PubMed ID: 30650178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid-derived suppressor cells in breast cancer.
    Markowitz J; Wesolowski R; Papenfuss T; Brooks TR; Carson WE
    Breast Cancer Res Treat; 2013 Jul; 140(1):13-21. PubMed ID: 23828498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.